Skip to content
Open access

Association of the G/G Genotype with Insulin Resistance, Dyslipidemia, And Hyperleptinemia

Sep 2026 · International journal of medical science and dental health · Vol 12, pp. 199-210 · 0 citations

TL;DR

The G/G genotype of the LEPR rs1137100 polymorphism was associated with obesity and a more adverse metabolic phenotype, however, this genotype did not independently differentiate between obesity severity categories.

Abstract

Background. Obesity is a multifactorial disease arising from interactions among environmental, behavioural, metabolic, and genetic factors. The leptin signalling system is a key component of the central regulation of energy balance. The rs1137100 polymorphism of the leptin receptor gene (LEPR) results in the Lys109Arg amino acid substitution and may be associated with variability in leptin sensitivity and the metabolic characteristics of obesity. However, findings vary considerably across populations. Objective. To evaluate the distribution of alleles and genotypes of the LEPR rs1137100 polymorphism in patients with overweight and obesity and to determine the associations between these genotypes and lipid metabolism, insulin resistance, and circulating leptin levels. Materials and Methods. The clinical cohort included 171 patients with overweight or obesity. Molecular genetic testing was performed in 74 patients (67 women and 7 men; mean age, 38.5 ± 1.4 years; mean body mass index [BMI], 37.7 ± 0.8 kg/m²). The control group consisted of 70 apparently healthy individuals with normal body weight (mean BMI, 22.6 ± 0.6 kg/m²). Genomic DNA was isolated from peripheral blood leukocytes using the NK-Magnit Base-96 kit. The rs1137100 polymorphism was genotyped using polymerase chain reaction followed by restriction fragment analysis. The A and G alleles and the A/A, A/G, and G/G genotypes were identified. The metabolic phenotype was assessed based on total cholesterol, low-density lipoprotein cholesterol, triglyceride and leptin concentrations, as well as the homeostatic model assessment of insulin resistance (HOMA-IR). Statistical analyses were performed using STATISTICA version 10.0 and Epi Info version 7.2.2.2. Results. The G/G genotype was identified in 32.4% of patients and 12.9% of controls (OR = 3.25; 95% CI, 1.42–7.44; p = 0.006, Fisher’s exact test). The frequency of the G/G genotype was 30.8% among patients with overweight or class I–II obesity and 36.4% among those with class III obesity; however, direct comparison according to obesity severity revealed no statistically significant differences. Within the patient group, the metabolic parameters progressively worsened across the A/A, A/G, and G/G genotypes. Compared with A/A carriers, G/G carriers had higher levels of low-density lipoprotein cholesterol (3.71 ± 0.05 vs 3.03 ± 0.04 mmol/L), triglycerides (2.23 ± 0.03 vs 1.64 ± 0.03 mmol/L), total cholesterol (5.81 ± 0.06 vs 4.95 ± 0.08 mmol/L), HOMA-IR (4.34 ± 0.04 vs 2.81 ± 0.05), and leptin (29.87 ± 0.80 vs 21.30 ± 0.90 ng/mL). Conclusion. In the study population, the G/G genotype of the LEPR rs1137100 polymorphism was associated with obesity and a more adverse metabolic phenotype. However, this genotype did not independently differentiate between obesity severity categories. These findings suggest that the G/G genotype may be considered a candidate marker of a metabolically adverse obesity phenotype, although confirmation in larger independent cohorts and multivariable models is required.

Read PDF

Similar papers

Open access Sep 2026

Associations of bone metabolism genes with obesity phenotypes

Introduction . Childhood obesity has reached pandemic proportions, yet it remains unclear how genetic factors regulating bone metabolism influence the development of obesity and its metabolic complications, as well as bone mineral density in this group of patients. Aim. To establish associations between polymorphic...

E. Kondratyeva, N. A. Tsurina, E. Loshkova et al. · 0 citations
Open access Sep 2026

The role of the ADRB2 gene rs1042714 polymorphism in shaping the metabolic response in patients with early disturbances of carbohydrate metabolism

Background. Individual variability in therapeutic response at the early stages of carbohydrate metabolism disorders is largely determined by genetic factors. One of the key genes involved in the regulation of energy homeostasis is ADRB2, which encodes the β₂-adrenergic receptor. The rs1042714 polymorphism may influence...

T. A. Kiseleva, F. Valeeva, M. S. Medvedeva et al. · 0 citations
Open access Sep 2026

Dyslipidemia as a Predictor of Liver Dysfunction, Glycaemic Control and Insulin Resistance: A Cross-Sectional Study

Dyslipidemia (DL), a common metabolic disorder, negatively influences the regulation of glycemia, liver function and insulin sensitivity and is a crucial factor in the dramatic increase in metabolic diseases. In India, the prevalence ranges from 15–20% in rural populations to 25–30% indicating the wide-spread prevalenc...

Naveen Kumar Billa, Darapuneni Radhika Chowdary, Sainath S. B. et al. · 0 citations
Open access Sep 2026

Association of Insulin Receptor Substrate 1 Gene Polymorphism (Rs2943640) with Glibenclamide Therapeutic Response in Iraqi Patients with Type 2 Diabetes Mellitus

Objective: This study aims to evaluate the association of the insulin receptor substrate 1 (IRS1) rs2943640 single nucleotide polymorphism (SNP) with the effectiveness of glibenclamide therapy in Iraqi diabetic patients treated with glibenclamide. Methods: This cross-sectional study was conducted in Karbala City, locat...

Mohammed Mahmood Abedalhussein, Mohammed Ibrahim Rasool, Suzanne Jubair Abbas · 0 citations
Open access Sep 2026

Defining metabolic heterogeneity in polyendocrine metabolic ovarian syndrome based on the MTHFR C677T polymorphism: the potential pathway role of homocysteine

Polyendocrine Metabolic Ovarian Syndrome (PMOS) is characterized by diverse endocrine and metabolic abnormalities. Patients differ substantially in obesity, insulin resistance, and cardiometabolic risk. Homocysteine (HCY) is associated with insulin resistance and metabolic abnormalities in patients with PMOS, and the m...

Li-Dong Zhao, Pei-Pei Li, Jin-Hua Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.